![]() | |
Supplier Name | BOC Sciences |
Contact | Linna Green |
Tel | +16314854226 |
Mobile | +16314854226 |
info@bocsci.com | |
Website | https://www.bocsci.com/ |
https://www.linkedin.com/company/boc-sciences |
Product Name | Imatinib Mesylate |
Synonyms | Glivec STI-571 gleevec Imatinibmesylate Imatinib Mesylate imatinib mesilate IMATINIB BASE(IMA-3) |
CAS | 220127-57-1 |
EINECS | 606-892-3 |
Chemical Formula | C30H35N7O4S |
Molecular Weight | 589.71 |
inchi | InChI=1/C29H31N7O.CH4O3S/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36 1-5(2,3)4/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34) |
Package | 10 g |
Price | $199 |
Descriptions | Imatinib mesylate Imatinib (INN), marketed by Novartis as Gleevec (Canada, South Africa and the USA) or Glivec (Australia, Europe and Latin America), and sometimes referred to by its investigational name STI-571, is a tyrosine-kinase inhibitor used in the treatment of multiple cancers, most notably Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML). |
Supplier Website | https://natuprod.bocsci.com/product/imatinib-mesylate-cas-220127-57-1-333257.html |
Last Update | 2025-04-30 11:27:47 |